Literature DB >> 8732865

Transcriptional expression of Epstein-Barr virus genes and proto-oncogenes in north African nasopharyngeal carcinoma.

F Sbih-Lammali1, D Djennaoui, H Belaoui, A Bouguermouh, G Decaussin, T Ooka.   

Abstract

Cases of nasopharyngeal carcinoma (NPC) from North Africa show an unusual bimodal age distribution. As elsewhere, the tumor is closely associated with the presence of Epstein-Barr virus (EBV). The expression of EBV genes and c-onc genes was studied in biopsy specimens from tumors at different clinical stages from 11 young (10 to 30-year-old) and 11 adult (30 to 65-year-old) patients. It was found that the two age groups do not differ in their pattern of gene expression, that there is a tendency for later stage biopsies to express more viral and c-onc transcripts, and that samples expressing larger numbers of EBV genes also tend to express many different c-onc specificities.

Entities:  

Mesh:

Year:  1996        PMID: 8732865     DOI: 10.1002/(SICI)1096-9071(199605)49:1<7::AID-JMV2>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

Review 1.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Synergism of BARF1 with Ras induces malignant transformation in primary primate epithelial cells and human nasopharyngeal epithelial cells.

Authors:  Richeng Jiang; Giulia Cabras; Wang Sheng; Yixin Zeng; Tadamasa Ooka
Journal:  Neoplasia       Date:  2009-09       Impact factor: 5.715

3.  The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.

Authors:  L D Strockbine; J I Cohen; T Farrah; S D Lyman; F Wagener; R F DuBose; R J Armitage; M K Spriggs
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Effect of Epstein-Barr virus infection on global gene expression in nasopharyngeal carcinoma.

Authors:  Yuan-Chii Gladys Lee; Yu-Chyi Hwang; Kuang-Chi Chen; Yong-Shiang Lin; Dah-Yeou Huang; Tao-Wei Huang; Cheng-Yan Kao; Han-Chung Wu; Chin-Tarng Lin; Chi-Ying F Huang
Journal:  Funct Integr Genomics       Date:  2006-09-19       Impact factor: 3.410

5.  Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases.

Authors:  D P Hayes; A A Brink; M B Vervoort; J M Middeldorp; C J Meijer; A J van den Brule
Journal:  Mol Pathol       Date:  1999-04

6.  Cyclin D1 expression is induced by viral BARF1 and is overexpressed in EBV-associated gastric cancer.

Authors:  Thorsten Wiech; Elisabeth Nikolopoulos; Silke Lassman; Timo Heidt; Anja Schöpflin; Mario Sarbia; Martin Werner; Yuko Shimizu; Emna Sakka; Tadamasa Ooka; Axel zur Hausen
Journal:  Virchows Arch       Date:  2008-04-25       Impact factor: 4.064

7.  Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR.

Authors:  A A Brink; M B Vervoort; J M Middeldorp; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  BAMHI DNA fragment H-polymorphism of Epstein-Barr virus is associated with the mutations present in an 89 BP sequence localized in EBNA2 gene.

Authors:  Wang Sheng; Abdelmadjide Bouguermouh; Maklouf Bouzid; Djamel Djennaoui; Tadamasa Ooka
Journal:  Virus Genes       Date:  2004-08       Impact factor: 2.332

9.  EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.

Authors:  Abdelmajid Khabir; Hela Karray; Sandrine Rodriguez; Mathieu Rosé; Jamel Daoud; Mounir Frikha; Tahia Boudawara; Jaap Middeldorp; Rachid Jlidi; Pierre Busson
Journal:  Virol J       Date:  2005-04-20       Impact factor: 4.099

10.  Posttransplant lymphoproliferative disorders.

Authors:  Hazem A H Ibrahim; Kikkeri N Naresh
Journal:  Adv Hematol       Date:  2012-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.